Shanghai Obio Technology (Group) Corp., Ltd. (SHA:688238)

China flag China · Delayed Price · Currency is CNY
7.71
+0.38 (5.18%)
At close: Mar 6, 2026
Market Cap4.86B +48.6%
Revenue (ttm)267.66M +7.9%
Net Income-220.72M
EPS-0.35
Shares Out630.31M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume19,657,721
Average Volume9,226,522
Open7.36
Previous Close7.33
Day's Range7.27 - 7.73
52-Week Range4.49 - 9.20
Beta0.60
RSI52.58
Earnings DateApr 21, 2026

About SHA:688238

Shanghai Obio Technology (Group) Corp., Ltd., a biotechnology company, engages in the provision of technical services for the field of regenerative medicine and anti-aging in China. The company offers customized plasmid design and viral vector packaging services; AAV serotypes and tissue-specific promoters to support scientific research; and research grade, NHP Grade, cGMP grade vector manufacturing process, for basic research, translational research and clinical trials. It also provides CDMO services encompassing process development, analytica... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2013
Employees 678
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 688238
Full Company Profile

Financial Performance

In 2025, SHA:688238's revenue was 267.66 million, an increase of 7.86% compared to the previous year's 248.15 million. Losses were -220.72 million, -31.41% less than in 2024.

Financial Statements